Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-26 Purchase |
2024-03-27 8:28 pm |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
110,321 | $3.7263 | $411,094 | 570,814 (Indirect Direct) |
View |
| 2024-03-26 Purchase |
2024-03-27 8:27 pm |
Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer |
100,000 | $3.75 | $375,000 | 354,958 (Indirect) |
View |
| 2023-01-17 Purchase |
2024-02-14 4:35 pm |
Summit Therapeutics Inc. | SMMT | Xia Yu Director |
31,523,530 | $1.5131 | $47,699,707 | 10,000,000 (Indirect) |
View |
| 2023-12-12 Purchase |
2023-12-13 5:11 pm |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
5,000 | $2.07 | $10,350 | 25,384,293 (Indirect Direct) |
View |
| 2023-12-13 Purchase |
2023-12-13 4:49 pm |
Summit Therapeutics Inc. | SMMT | Dhingra Ankur Chief Financial Officer |
20,400 | $2.1693 | $44,254 | 254,958 (Indirect) |
View |
| 2023-10-13 Purchase |
2023-10-16 4:06 pm |
Summit Therapeutics Inc. | SMMT | Soni Manmeet Singh Chief Operating Officer |
2,976,190 | $1.68 | $4,999,999 | 16,976,190 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-08 Exercise |
2025-04-09 5:19 pm |
2020-06-24 2029-12-24 |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer 10% Owner |
3,985,055 | $0 | 591,418,593 (Indirect) |
View |
| 2025-04-08 Exercise |
2025-04-09 5:19 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer 10% Owner |
3,985,055 | $1.58 | 591,418,593 (Indirect) |
View |
| 2025-04-08 Exercise |
2025-04-09 5:12 pm |
2020-06-24 2029-12-24 |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Co-Chief Executive Officer 10% Owner |
3,985,055 | $0 | 591,418,593 (Direct) |
View |
| 2025-04-08 Exercise |
2025-04-09 5:12 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Co-Chief Executive Officer 10% Owner |
3,985,055 | $1.58 | 591,418,593 (Direct) |
View |
| 2025-01-12 Option Award |
2025-01-14 4:06 pm |
N/A 2035-01-12 |
Summit Therapeutics Inc. | SMMT | Anand Bhaskar Chief Accounting Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 7:49 pm |
N/A 2035-01-02 |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Co-Chief Executive Officer 10% Owner |
10,724 | $9.18 | 604,808,423 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 7:39 pm |
N/A 2035-01-02 |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer 10% Owner |
10,724 | $9.18 | 591,503,862 (Indirect) |
View |
| 2025-01-02 Option Award |
2025-01-06 7:30 pm |
N/A 2035-01-02 |
Summit Therapeutics Inc. | SMMT | Huber Jeff Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 7:24 pm |
N/A 2035-01-02 |
Summit Therapeutics Inc. | SMMT | Xia Yu Director |
5,438 | $9.18 | 40,438 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 7:24 pm |
N/A 2035-01-02 |
Summit Therapeutics Inc. | SMMT | Xia Yu Director |
35,000 | $0 | 40,438 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 7:17 pm |
N/A 2035-01-02 |
Summit Therapeutics Inc. | SMMT | Cesano Alessandra Director |
3,073 | $9.18 | 38,073 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 7:17 pm |
N/A 2035-01-02 |
Summit Therapeutics Inc. | SMMT | Cesano Alessandra Director |
35,000 | $0 | 38,073 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 7:11 pm |
N/A 2035-01-02 |
Summit Therapeutics Inc. | SMMT | Ronaghi Mostafa Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 7:05 pm |
N/A 2035-01-02 |
Summit Therapeutics Inc. | SMMT | Clark Kenneth A Director |
16,991 | $9.18 | 51,991 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 7:05 pm |
N/A 2035-01-02 |
Summit Therapeutics Inc. | SMMT | Clark Kenneth A Director |
35,000 | $0 | 51,991 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 6:57 pm |
N/A 2035-01-02 |
Summit Therapeutics Inc. | SMMT | Booth Robert F. Director |
6,855 | $9.18 | 41,855 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 6:57 pm |
N/A 2035-01-02 |
Summit Therapeutics Inc. | SMMT | Booth Robert F. Director |
35,000 | $0 | 41,855 (Direct) |
View |
| 2024-10-11 Option Award |
2024-10-15 5:08 pm |
N/A 2034-10-11 |
Summit Therapeutics Inc. | SMMT | Clark Kenneth A Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-10-03 Exercise |
2024-10-03 4:54 pm |
2020-06-24 2029-12-24 |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer |
315,681 | $0 | 35,738,442 (Indirect) |
View |
| 2024-10-03 Exercise |
2024-10-03 4:54 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer |
315,681 | $1.58 | 35,738,442 (Indirect) |
View |
| 2024-09-11 Option Award |
2024-09-13 7:29 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer |
44,052 | $22.7 | 35,422,761 (Indirect) |
View |
| 2024-09-11 Option Award |
2024-09-13 6:25 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Co-Chief Executive Officer 10% Owner |
3,325,991 | $22.7 | 551,695,096 (Direct) |
View |
| 2024-09-11 Option Award |
2024-09-13 5:40 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Huber Jeff Director |
44,052 | $22.7 | 50,052 (Indirect) |
View |
| 2024-09-11 Option Award |
2024-09-13 5:29 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Soni Manmeet Singh COO and CFO |
44,052 | $22.7 | 3,020,242 (Direct) |
View |
| 2024-09-11 Option Award |
2024-09-13 5:26 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Anand Bhaskar Chief Accounting Officer |
22,026 | $22.7 | 131,426 (Direct) |
View |
| 2024-08-23 Option Award |
2024-08-23 4:44 pm |
N/A 2033-10-13 |
Summit Therapeutics Inc. | SMMT | Soni Manmeet Singh COO and CFO |
2,800,000 | $0 | 2,800,000 (Direct) |
View |
| 2024-08-23 Option Award |
2024-08-23 4:42 pm |
N/A 2032-06-28 |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
2,757,640 | $0 | 2,757,640 (Direct) |
View |
| 2024-06-27 Option Award |
2024-06-27 5:20 pm |
N/A 2034-06-27 |
Summit Therapeutics Inc. | SMMT | Huber Jeff Director |
217,883 | $0 | 417,883 (Direct) |
View |
Ownership |
2024-06-27 5:16 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Huber Jeff Director |
0 | $0 | 6,000 (Indirect) |
View |
| 2024-04-11 Option Award |
2024-04-15 09:21 am |
N/A 2034-04-11 |
Summit Therapeutics Inc. | SMMT | Ronaghi Mostafa Director |
225,315 | $0 | 425,315 (Direct) |
View |
| 2024-04-02 Option Award |
2024-04-04 5:52 pm |
N/A 2034-04-02 |
Summit Therapeutics Inc. | SMMT | Soni Manmeet Singh Chief Operating Officer |
1,100,000 | $0 | 1,100,000 (Direct) |
View |
| 2024-04-02 Option Award |
2024-04-04 5:47 pm |
N/A 2034-04-02 |
Summit Therapeutics Inc. | SMMT | Anand Bhaskar Chief Accounting Officer |
600,000 | $0 | 600,000 (Direct) |
View |
Ownership |
2024-04-04 5:43 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Anand Bhaskar Chief Accounting Officer |
0 | $0 | 109,400 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:33 pm |
N/A 2034-01-02 |
Summit Therapeutics Inc. | SMMT | Cesano Alessandra Director |
35,000 | $0 | 91,363 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:33 pm |
N/A 2034-01-02 |
Summit Therapeutics Inc. | SMMT | Cesano Alessandra Director |
21,363 | $1.32 | 91,363 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:27 pm |
N/A 2034-01-02 |
Summit Therapeutics Inc. | SMMT | Booth Robert F. Director |
35,000 | $0 | 117,651 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:27 pm |
N/A 2034-01-02 |
Summit Therapeutics Inc. | SMMT | Booth Robert F. Director |
47,651 | $1.32 | 117,651 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:24 pm |
N/A 2034-01-02 |
Summit Therapeutics Inc. | SMMT | Clark Kenneth A Director |
35,000 | $0 | 140,492 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:24 pm |
N/A 2034-01-02 |
Summit Therapeutics Inc. | SMMT | Clark Kenneth A Director |
70,492 | $1.32 | 140,492 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:22 pm |
N/A 2034-01-02 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
35,000 | $0 | 122,575 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:22 pm |
N/A 2034-01-02 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
52,575 | $1.32 | 122,575 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:19 pm |
N/A 2034-01-02 |
Summit Therapeutics Inc. | SMMT | Xia Yu Director |
235,000 | $0 | 270,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:16 pm |
N/A 2034-01-02 |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Co-Chief Executive Officer 10% Owner |
74,545 | $1.32 | 74,545 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-13 5:11 pm |
2023-12-11 2025-06-30 |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
805,495 | $0 | 25,384,293 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-13 5:11 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
315,681 | $1.58 | 25,384,293 (Indirect) |
View |
| 2023-12-11 Exercise |
2023-12-13 5:11 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
489,814 | $1.44 | 25,384,293 (Direct) |
View |
| 2023-10-13 Option Award |
2023-10-16 4:08 pm |
N/A 2033-10-13 |
Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer |
11,988,198 | $0 | 11,988,198 (Direct) |
View |
| 2023-10-13 Option Award |
2023-10-16 4:06 pm |
N/A 2033-10-13 |
Summit Therapeutics Inc. | SMMT | Soni Manmeet Singh Chief Operating Officer |
14,000,000 | $0 | 16,976,190 (Direct) |
View |